Regulatory submissions
An operator drafts the section from your study reports, in your own template. Each value carries its source and is checked against your other documents; your regulatory lead signs off.
Module 2.6.6 Toxicology Written Summary · 2.6.6.3 Repeat-dose toxicity
Calder IND template v3 (.docx)
In the 28-day oral study in rats, CLD-207 was given once daily at 15, 50 and 150 mg/kg/day.
The no-observed-adverse-effect level (NOAEL) was 50 mg/kg/day; at 150 mg/kg/day, ALT rose up to 2.4-fold and returned to baseline by the end of the 14-day recovery period.
In the 28-day study in dogs, the NOAEL was 20 mg/kg/day, the highest dose tested.
Waiting for the regulatory lead's yes before anything uploads.
Upload the Module 2.6.6 draft to SharePoint › IND CLD-207 › Module 2R. Lindqvist, regulatory affairs lead
Illustrative draft: a fictional compound, studies and values that show the output's shape.
Enterprises running operators on Alomana
Reads reports, IB, CMC records, scans
Writes into your Word template
Drafts sections and summary tables
Notes the source of every value
Checks values across documents, in code
Drafts answers to agency questions
SharePoint or Drive, plus a folder of templates, SOPs and prior submissions.
Your template, every value sourced and checked across documents.
Your regulatory lead edits and approves. Then it uploads and logs it.
FDA information request · Q3
Justify the selection of 150 mg/kg/day as the high dose in Study TX-0412.
Illustrative response
The high dose was selected from the 7-day dose-range-finding study TX-0398, in which 300 mg/kg/day caused body-weight loss of more than 10%. TX-0398 Table 4
150 mg/kg/day was expected to produce identifiable toxicity without exceeding the maximum tolerated dose, as stated in the study plan. TX-0412 §4.1
Drafted for R. Lindqvist to edit and sign
The operator stops at a reviewed draft. Publishing and submission stay with your team.
A custom operator typically goes live in up to 4 weeks.
An autonomous agent that drafts sections of submission documents from your own sources. It reads your study reports, IB and prior modules, writes the section into your template, notes the source of every value, and checks each value against its source and your other documents before your team reviews it.
No. It drafts for your regulatory team and stops there. Uploading a draft to SharePoint or Google Drive waits for a person's yes. eCTD assembly, publishing and submission stay with your team and your tools.
Module sections such as nonclinical and quality summaries and written summaries, plus answers to health authority questions, working from your study reports, IB, CMC records and prior submissions, in your own Word template.
Every value shows the report, table or page it came from. The operator compares each value with its source and with the same value in your other documents, in code, and lists every disagreement. Your team decides which document is right.
Not natively. It reads files from SharePoint, Google Drive or a knowledge folder you give it. A RIM or document management system connects through a remote MCP server for your deployment.
Alomana is ISO 27001 certified and GDPR-compliant, and your data is never used to train AI models. Enterprise deployments run single-tenant, in a dedicated instance, and every run is logged with input, output, tools and user.
Talk it over with sales: what the operator needs from your systems, and how it goes live.
Alomana is a secure enterprise AI platform where autonomous agents, called operators, run business processes end to end. Every run is fully auditable.